Onconetix, Inc. (ONCO)
NASDAQ: ONCO · Real-Time Price · USD
0.6577
-0.0254 (-3.72%)
Sep 23, 2026, 2:04 PM EDT - Market open

Onconetix Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
0.650.822.520.06--
Revenue Growth
-51.33%-67.70%4217.31%---
Gross Profit
0.520.631.06-1.13--
Operating Income
-7.69-6.34-10.33-17.85-13.18-3.42
Net Income
-10.2-15.53-58.9-37.41-13.52-4.04
Earnings Per Share
-17.16-828.14----
EPS Growth
------

Revenue by Geography

Fiscal YearTTMFY 2025FY 2024
Period EndingJun '26 Dec '25 Dec '24
United Kingdom
0.040.020.02
Switzerland
0.610.82.44
United States
--0.06
Total
0.650.822.52

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
5.945.220.654.5525.751.93
Total Debt
0.190.059.459.89--
Net Cash (Debt)
5.765.17-8.8-5.3325.751.93
Net Cash Growth
----1235.39%-55.24%
Net Cash Per Share
9.68275.77----

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-10.31-9.68-10.5-13.58-8.68-2.04
Capital Expenditures
---0.03-9.58-0.01-0
Free Cash Flow
-10.31-9.68-10.52-23.16-8.68-2.05
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
80.40%77.62%41.80%---
Operating Margin
-1190.29%-778.16%-409.30%-30526.38%--
Pretax Margin
-1578.71%-1720.91%-2366.62%-64008.02%--
Profit Margin
-1578.79%-1904.77%-2333.39%-63986.48%--
FCF Margin
-1596.10%-1186.99%-416.95%-39620.44%--

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
4.182.982.0762.18--